JOURNAL OF SHANDONG UNIVERSITY(NATURAL SCIENCE) ›› 2025, Vol. 60 ›› Issue (9): 24-30.doi: 10.6040/j.issn.1671-9352.0.2025.115

Previous Articles    

Preparation of Acorus tatarinowii volatile oil nasal thermosensitive in situ gel

CHEN Liang1, DU Lilin2, XIAO Yaxin1, LI Jiaxin1*   

  1. 1. College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, China;
    2. The First Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang 550001, Guizhou, China
  • Published:2025-09-10

Abstract: This study successfully prepared a nasal thermosensitive in situ gel of Acorus tatarinowii volatile oil. The complexation process parameters of Acorus tatarinowii volatile oil were optimized using orthogonal design method. Meanwhile, taking the mass fractions of poloxamer 407(P407)and poloxamer 188(P188)as the key factors and phase transition temperature as the index, the binomial fitting was carried out using central composite design-response surface methodology. Based on this, the preparation process of the nasal thermosensitive in situ gel was further optimized, and its inhibitory activity against γ-aminobutyric acid transaminase(GABA-T)was assessed. The results indicated that the optimal inclusion complexation process parameters for Acorus tatarinowii volatile oil were as follows: the feeding ratio of volatile oil to β-cyclodextrin(β-CD)was 1 mL∶5 g, the feeding ratio of β-CD to H2O was 1 g∶35 mL, and the complexation temperature was 30 ℃. When the mass fraction of P407 was 19.13% and the mass fraction of P188 was 1.08%, the phase transition temperature of the prepared in situ gel was 32 ℃, which had a promising application prospect. Moreover, the gel exhibited a dose-dependent inhibitory effect on GABA-T, with an IC50 value of 215.7 μg/mL. The thermosensitive nasal in situ gel preparation process established in this study was efficient and feasible, providing a solid theoretical basis and technical support for the development of Acorus tatarinowii volatile oil and its application in the treatment of nervous system diseases.

Key words: Acorus tatarinowii Schott, central composite design-response surface methodology, in situ gel, volatile oil

CLC Number: 

  • R285
[1] 陈亮,方成维,蒙吉,等. 石菖蒲治疗阿尔茨海默病的作用机制[J]. 山东大学学报(理学版),2024,59(11):64-73. CHEN Liang, FANG Chengwei, MENG Ji, et al. Mechanism of Acotus tatarinowii Schott in treating Alzheimers disease[J]. Journal of Shandong University(Natural Science), 2024, 59(11):64-73.
[2] 杨双玲,薛艳芳,陈华师,等. 指纹图谱分析石菖蒲及不同炮制品挥发性成分[J]. 江西中医药大学学报,2024,36(4):65-71. YANG Shuangling, XUE Yanfang, CHEN Huashi, et al. Fingerprint analysis of volatile components in Acorus Calamus and different processed products[J]. Journal of Jiangxi University of Chinese Medicine, 2024, 36(4):65-71.
[3] LEE Y C, KAO S T, CHENG C Y. Acorus tatarinowii Schott extract reduces cerebral edema caused by ischemia-reperfusion injury in rats: involvement in regulation of astrocytic NKCC1/AQP4 and JNK/iNOS-mediated signaling[J]. BMC Complementary Medicine and Therapies, 2020, 20(1):374.
[4] 郭美彤,赵佳奇,韩诚,等. 石菖蒲药效物质基础和作用机制研究进展[J]. 中药药理与临床,2019,35(2):179-184. GUO Meitong, ZHAO Jiaqi, HAN Cheng, et al. Study of the substance basis and mechanism of effects of Acorus tatarinowii Schott[J]. Pharmacology and Clinics of Chinese Materia Medica, 2019, 35(2):179-184.
[5] 刘春娟,房彩连,朱羽,等. 石菖蒲复方的临床应用研究概况[J]. 食品与药品,2023,25(3):256-261. LIU Chunjuan, FANG Cailian, ZHU Yu, et al. Research summary of clinical application of Acorus Tatarinowii Schott compound[J]. Food and Drug, 2023, 25(3):256-261.
[6] 谷福根,樊慧敏,丛志新,等. 盐酸多奈哌齐鼻用温敏凝胶剂在大鼠脑组织内的药代动力学及脑靶向性研究[J]. 中国临床药理学杂志,2020,36(19):3106-3109. GU Fugen, FAN Huimin, CONG Zhixin, et al. Study on cerebral pharmacokinetics of donepezil hydrochloride thermo-sensitive nasal gel and its brain targeting in rats[J]. The Chinese Journal of Clinical Pharmacology, 2020, 36(19):3106-3109.
[7] 袁振海,尚立霞,况成裕,等. 温敏型鼻用原位凝胶的研究进展[J]. 食品与药品,2018,20(5):386-389. YUAN Zhenhai, SHANG Lixia, KUANG Chengyu, et al. Research progress on thermo-responsive in situ gel for nasal delivery[J]. Food and Drug, 2018, 20(5):386-389.
[8] 王雨欣,常金花,杨菲,等. 星点设计-效应面法优化野黄芩苷镁温敏型鼻用原位凝胶的制备[J]. 亚太传统医药,2022,18(4):66-71. WANG Yuxin, CHANG Jinhua, YANG Fei, et al. Optimization of scutellarin magnesium thermosensitive nasal in situ gel by central composite design response surface methodology[J]. Asia-Pacific Traditional Medicine, 2022, 18(4):66-71.
[9] 张利竣,吴盈盈,吴瑾瑾,等. 灯盏花素温敏型鼻用原位凝胶的体外释放和生物黏附性考察[J]. 中国现代应用药学,2020,37(23):2863-2867. ZHANG Lijun, WU Yingying, WU Jinjin, et al. Study on in vitro release and bioadhesion of breviscapine temperature-sensitive nasal in situ gel[J]. Chinese Journal of Modern Applied Pharmacy, 2020, 37(23):2863-2867.
[10] 张昆,熊磊,程欣,等. 苍艾油传递体凝胶的制备及其体外释药研究[J]. 中国医院药学杂志,2021,41(14):1385-1389. ZHANG Kun, XIONG Lei, CHENG Xin, et al. Preparation of Cangai oil transfersomes gel and its drug release in vitro[J]. Chinese Journal of Hospital Pharmacy, 2021, 41(14):1385-1389.
[11] 王文苹,刘珍珍,常道潇,等. 甘草酸水溶液的凝胶化特性[J]. 中国医院药学杂志,2020,40(16):1724-1727. WANG Wenping, LIU Zhenzhen, CHANG Daoxiao, et al. Gelation properties of glycyrrhizin aqueous solution[J]. Chinese Journal of Hospital Pharmacy, 2020, 40(16):1724-1727.
[12] 苏梦,许汉林,胡奎,等. 石菖蒲挥发油β-环糊精、羟丙基-β-环糊精包合物的制备及稳定性[J]. 湖北中医药大学学报,2017,19(3):25-29. SU Meng, XU Hanlin, HU Kui, et al. Study on the preparation and stability of beta-CD, HP-β-CD inclusion complex in volatile oil of acorus tatarinowii[J]. Journal of Hubei University of Chinese Medicine, 2017, 19(3):25-29.
[13] YUAN Y, CUI Y, ZHANG L, et al. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide[J]. International Journal of Pharmaceutics, 2012, 430(1/2):114-119.
[14] 樊慧敏,丛志新,谷福根. 盐酸多奈哌齐鼻用温敏原位凝胶的制备及其体外性质评价[J]. 中南药学,2018,16(9):1194-1199. FAN Huimin, CONG Zhixin, GU Fugen. Preparation and in vitro properties of thermosensitive in situ nasal gel of donepezil hydrochloride[J]. Central South Pharmacy, 2018, 16(9):1194-1199.
[15] ADJOBIMEY M, BEHR M A, MENZIES D. Individualized treatment duration in tuberculosis treatment:precision versus simplicity[J]. American Journal of Respiratory and Critical Care Medicine, 2021, 204(9):1013-1014.
[16] DE BOER T, BRUINVELS J. Assay and properties of 4-aminobutyric-2-oxoglutaric acid transaminase and succinic semialdehyde dehydrogenase in rat brain tissue[J]. Journal of Neurochemistry, 1977, 28(3):471-478.
[17] 李碧,方雄,龚晏,等. γ-氨基丁酸转氨酶抑制剂筛选方法的建立及其在天麻成分筛选中的应用[J]. 中草药, 2016, 47(3):454-458. LI Bi, FANG Xiong, GONG Yan, et al. Establishment of screening method for γ-aminobutyric acid transaminase inhibitor and its application in screening constituents in Gastrodiae Rhizoma[J]. Chinese Traditional and Herbal Drugs, 2016, 47(3):454-458.
[18] 阿布都艾则孜·艾尔肯,阿丽亚·依拉木,艾尔菲丁·阿尼娃尔,等. 没食子温敏原位凝胶质量标准研究[J]. 医药导报,2022,41(8):1187-1192. ARKIN Abdulaziz, ELHAM Aliya, ANWAR Arfidin, et al. Study on the quality standard of thermosensitive in situ gel of quercus infectoria galls[J]. Herald of Medicine, 2022, 41(8):1187-1192.
[19] KOURDOUGLI N, PELLEGRINO C, RENKO J M, et al. Depolarizing γ-aminobutyric acid contributes to glutamatergic network rewiring in epilepsy[J]. Annals of Neurology, 2017, 81(2):251-265.
[20] LIU M Q, WANG T, WANG Q L, et al. Structure-guided discovery of food-derived GABA-T inhibitors as hunters for anti-anxiety compounds[J]. Food & Function, 2022, 13(24):12674-12685.
[1] Liang CHEN, Chengwei FANG, Ji MENG, Xiuping MA, Dan ZHU, Jiaxin LI. Mechanism of Acotus tatarinowii Schott in treating Alzheimer's disease [J]. JOURNAL OF SHANDONG UNIVERSITY(NATURAL SCIENCE), 2024, 59(11): 64-73, 92.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!